This article is available to members only. Please enjoy the abstract for free. Subscribe for instant access to the full article.

This content is restricted to subscribers

Continue Reading...

Did you know members enjoy unlimited free PDF downloads as part of their subscription? Subscribe today for instant access to this article and our entire library in your preferred format. Alternatively, you can purchase the PDF of this article individually.

Subscribe Now

Already a member? Login

Purchase PDF for $40

Members enjoy free PDF downloads on all articles. Join today

  1. Department of Psychiatry, Geisel Medical School at Dartmouth College, Hanover, New Hampshire
  2. White River Junction VA Medical Center, White River Junction, Vermont
  3. Corresponding author: Bradley V. Watts, MD MPH White River Junction VAMC, 215 N. Main St, White River Junction, VT ([email protected]).
  4. White River Junction VA Medical Center, White River Junction, Vermont
  5. Department of Psychiatry, Geisel Medical School at Dartmouth College, Hanover, New Hampshire
  6. White River Junction VA Medical Center, White River Junction, Vermont
  1. Tharyan P, Adams CE. Electroconvulsive therapy for schizophrenia. Cochrane Database Syst Rev. 2005;(2):CD000076. PubMed
  2. Bahji A, Hawken ER, Sepehry AA, et al. ECT beyond unipolar major depression: systematic review and meta-analysis of electroconvulsive therapy in bipolar depression. Acta Psychiatr Scand. 2019;139(3):214–226. PubMed
  3. Rasmussen KG. Sham electroconvulsive therapy studies in depressive illness: a review of the literature and consideration of the placebo phenomenon in electroconvulsive therapy practice. J ECT. 2009;25(1):54–59. PubMed CrossRef
  4. Read J, Bentall R. The effectiveness of electroconvulsive therapy: a literature review. Epidemiol Psichiatr Soc. 2010;19(4):333–347. PubMed CrossRef
  5. Kellner CH, Fink M, Knapp R, et al. Relief of expressed suicidal intent by ECT: a consortium for research in ECT study. Am J Psychiatry. 2005;162(5):977–982. PubMed CrossRef
  6. UK ECT Review Group. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet. 2003;361(9360):799–808. PubMed CrossRef
  7. Greenberg RM, Kellner CH. Electroconvulsive therapy: a selected review. Am J Geriatr Psychiatry. 2005;13(4):268–281. PubMed CrossRef
  8. Sackeim HA, Haskett RF, Mulsant BH, et al. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. JAMA. 2001;285(10):1299–1307. PubMed CrossRef
  9. Fink M, Kellner CH, McCall WV. The role of ECT in suicide prevention. J ECT. 2014;30(1):5–9. PubMed CrossRef
  10. Huston PE, Locher LM. Involutional psychosis; course when untreated and when treated with electric shock. Arch Neurol Psychiatry. 1948;59(3):385–394. PubMed CrossRef
  11. Huston PE, Locher LM. Manic-depressive psychosis; course when treated and untreated with electric shock. Arch Neurol Psychiatry. 1948;60(1):37–48. PubMed CrossRef
  12. Tanney BL. Electroconvulsive therapy and suicide. Suicide Life Threat Behav. 1986;16(2):198–222. PubMed CrossRef
  13. Ross EL, Zivin K, Maixner DF. Cost-effectiveness of electroconvulsive therapy vs pharmacotherapy/psychotherapy for treatment-resistant depression in the United States. JAMA Psychiatry. 2018;75(7):713–722. PubMed CrossRef
  14. Munk-Olsen T, Laursen TM, Videbech P, et al. All-cause mortality among recipients of electroconvulsive therapy: register-based cohort study. Br J Psychiatry. 2007;190(5):435–439. PubMed CrossRef
  15. Jørgensen MB, Rozing MP, Kellner CH, et al. Electroconvulsive therapy, depression severity and mortality: data from the Danish National Patient Registry. J Psychopharmacol. 2020;34(3):273–279. PubMed CrossRef
  16. Ahmadi N, Moss L, Simon E, et al. Efficacy and long-term clinical outcome of comorbid posttraumatic stress disorder and major depressive disorder after electroconvulsive therapy. Depress Anxiety. 2016;33(7):640–647. PubMed CrossRef
  17. Liang CS, Chung CH, Ho PS, et al. Superior anti-suicidal effects of electroconvulsive therapy in unipolar disorder and bipolar depression. Bipolar Disord. 2018;20(6):539–546. PubMed CrossRef
  18. Peltzman T, Shiner B, Watts BV. Effects of electroconvulsive therapy on short-term suicide mortality in a risk-matched patient population. J ECT. 2020;36(3):187–192. PubMed CrossRef
  19. Weiner RD, Reti IM. Key updates in the clinical application of electroconvulsive therapy. Int Rev Psychiatry. 2017;29(2):54–62. PubMed CrossRef
  20. McCarthy JF, Bossarte RM, Katz IR, et al. Predictive modeling and concentration of the risk of suicide: implications for preventive interventions in the US Department of Veterans Affairs. Am J Public Health. 2015;105(9):1935–1942. PubMed CrossRef
  21. Case BG, Bertollo DN, Laska EM, et al. Declining use of electroconvulsive therapy in United States general hospitals. Biol Psychiatry. 2013;73(2):119–126. PubMed CrossRef
  22. Weiner RD, Prudic J. Electroconvulsive therapy in the United States: how often is it used? Biol Psychiatry. 2013;73(2):105–106. PubMed CrossRef
  23. National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Care Services; Committee to Evaluate the Department of Veterans Affairs Mental Health Services. Evaluation of the Department of Veterans Affairs Mental Health Services. Washington, DC: National Academies Press; 2018. 2018.
  24. Gill SP, Kellner CH. Clinical practice recommendations for continuation and maintenance electroconvulsive therapy for depression: outcomes from a review of the evidence and a consensus workshop held in Australia in May 2017. J ECT. 2019;35(1):14–20. PubMed CrossRef
  25. Katz IR, McCarthy JF, Ignacio RV, et al. Suicide among veterans in 16 states, 2005 to 2008: comparisons between utilizers and nonutilizers of Veterans Health Administration (VHA) services based on data from the National Death Index, the National Violent Death Reporting System, and VHA administrative records. Am J Public Health. 2012;102(suppl 1):S105–S110. PubMed CrossRef
  26. Quan H, Li B, Couris CM, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676–682. PubMed CrossRef
  27. Duhamel A, Labreuche J, Gronnier C, et al. Statistical tools for propensity score matching. Ann Surg. 2017;265(6):E79–E80. PubMed CrossRef NLM
  28. Rossen LM, Hedegaard H, Khan D, et al. County-level trends in suicide rates in the US, 2005–2015. Am J Prev Med. 2018;55(1):72–79. PubMed CrossRef
  29. Chung DT, Ryan CJ, Hadzi-Pavlovic D, et al. Suicide rates after discharge from psychiatric facilities: a systematic review and meta-analysis. JAMA Psychiatry. 2017;74(7):694–702. PubMed CrossRef
  30. Na PJ, Yaramala SR, Kim JA, et al. The PHQ-9 Item 9 based screening for suicide risk: a validation study of the Patient Health Questionnaire (PHQ)-9 Item 9 with the Columbia Suicide Severity Rating Scale (C-SSRS). J Affect Disord. 2018;232:34–40. PubMed CrossRef